USP launches supplement IVP
This article was originally published in The Tan Sheet
Executive Summary
Argentinean ingredient producer Inter Farma is the first participant in USP's new Ingredient Verification Program for substances used in the manufacture of dietary supplements, the standard-setting organization announced March 31; the firm submitted chondroitin sulfate materials for verification. The organization's IVP process involves evaluation of quality systems and GMP compliance, quality control document review and lab evaluation of ingredient samples. Ingredients granted a USP-IVP verification mark also receive post-verification surveillance testing. USP and industry have urged FDA to allow the use of certificates of analysis in place of extensive batch-testing in supplement GMPs (1"The Tan Sheet" Sept. 1, 2003, p. 7)...
You may also be interested in...
Supplement GMPs Should Set Dissolution, Disintegration Requirements – USP
Dissolution or disintegration requirements for dietary supplements ought to be mandated by FDA in order to confirm product quality, the U.S. Pharmacopeia says in Aug. 11 comments on the supplement good manufacturing practices proposed rule
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.